TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 1 filers reported holding TANGO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,815,000 | +221.6% | 250,000 | -5.2% | 0.03% | +230.0% |
| Q2 2023 | $875,301 | -38.6% | 263,645 | -27.0% | 0.01% | -47.4% |
| Q1 2023 | $1,426,716 | -46.1% | 361,194 | -1.1% | 0.02% | -45.7% |
| Q4 2022 | $2,647,961 | +46.3% | 365,236 | -27.0% | 0.04% | +40.0% |
| Q3 2022 | $1,810,000 | -20.1% | 500,095 | 0.0% | 0.02% | -28.6% |
| Q2 2022 | $2,265,000 | -40.3% | 500,095 | 0.0% | 0.04% | -43.5% |
| Q1 2022 | $3,791,000 | -30.7% | 500,095 | +0.0% | 0.06% | -20.5% |
| Q4 2021 | $5,470,000 | -15.4% | 500,018 | -0.0% | 0.08% | -26.4% |
| Q3 2021 | $6,466,000 | – | 500,040 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $211,842,000 | 60.92% |
| Cormorant Asset Management, LP | 4,899,185 | $53,149,000 | 3.16% |
| Boxer Capital, LLC | 6,871,642 | $75,176,000 | 2.92% |
| Casdin Capital, LLC | 5,487,910 | $60,038,000 | 1.69% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $21,024,000 | 1.67% |
| Samsara BioCapital, LLC | 630,000 | $6,892,000 | 1.34% |
| TANG CAPITAL MANAGEMENT LLC | 468,750 | $5,128,000 | 1.03% |
| HARVARD MANAGEMENT CO INC | 708,385 | $7,750,000 | 0.73% |
| HHLR ADVISORS, LTD. | 3,873,982 | $42,381,000 | 0.66% |
| Southpoint Capital Advisors LP | 3,000,000 | $32,820,000 | 0.63% |